Curability (n = 310) | ||||
---|---|---|---|---|
Yes | No | p | ||
Gender | Male | 106 | 120 | 0.411 |
Female | 35 | 49 | ||
Age | <60 years | 72 | 96 | 0.312 |
≥60 years | 69 | 73 | ||
Cardia | Not involved | 86 | 143 | 0.000** |
Involved | 55 | 26 | ||
Gastric body | Not involved | 65 | 75 | 0.762 |
Involved | 76 | 94 | ||
Gastric antrum | Not involved | 72 | 51 | 0.000** |
Involved | 69 | 118 | ||
Number of regions | 1 | 84 | 106 | 0.355 |
2 | 55 | 57 | ||
3 | 2 | 6 | ||
Esophagus | Not involved | 97 | 161 | 0.000** |
Involved | 44 | 8 | ||
Duodenum | No | 136 | 157 | 0.171 |
Yes | 5 | 12 | ||
Signet ring cell carcinoma | No | 111 | 124 | 0.121 |
Partly | 26 | 31 | ||
Mainly | 4 | 14 | ||
T grade | 3 | 136 | 72 | 0.000** |
4 | 5 | 97 | ||
Borrmann type | I + II | 49 | 33 | 0.000** |
III | 86 | 28 | ||
IV | 6 | 21 | ||
Grading | Well and moderately differentiated | 20 | 9 | 0.046* |
Poorly differentiated | 115 | 118 |